Cyabra Approves 1-for-30 Reverse Stock Split Ahead of Nasdaq Compliance Deadline
Key Facts
Cyabra said its 1-for-30 reverse split of common stock, approved by shareholders at their annual meeting on November 10, is expected to take effect at market open on November 23, 2026. The move comes as the company faces the risk of being delisted from Nasdaq after being notified that it had not regained compliance with the market value of listed securities requirement. The company said Nasdaq staff notified it of the delisting decision on November 16. The split is intended, according to its disclosure, as an attempt to regain compliance with listing requirements, including the minimum bid price. Cyabra said trading will continue under the ticker CYAB, with a new CUSIP number after the split.
The share count disclosure reflects the mathematical effect of the split on the share base: 1,109,487 common shares were outstanding as of September 30, 2026, after giving retroactive effect to the 1-for-30 split. The company said the corresponding figure on December 31, 2025, was 100,652 shares, under the retroactive treatment in the disclosure. These figures show the share count recorded on those dates on a split-adjusted basis and are not an estimate of the number of shares before the split. In the market, Cyabra shares closed at $0.0998 on November 17. Innoviz shares closed at $0.1435 on the same day, amid two reverse-split announcements cited in the report.
But Cyabra’s announcement comes amid listing pressures that extend beyond its share price. The company cited its failure to meet Nasdaq’s $50,000,000 market value of listed securities requirement. It also said it failed to meet a minimum $15 million market value of publicly held shares and the minimum bid price requirement of $1.00 per share. The price shortfall relates to a 30-business-day period that ended on June 8, 2026. The company links the split to an attempt to address Nasdaq’s requirements, while the announcement alone does not mean compliance has been regained.
Cyabra faces a near-term deadline in its appeal of the delisting decision. The company said it intends to request a hearing, and that filing an appeal by November 23 will stay the trading suspension scheduled for market open on November 25. According to its disclosure, trading would have been suspended at that time if the company did not request an appeal. Separately, a deadline to regain compliance with the market value of publicly held shares requirement and the minimum bid price requirement expires on December 7, 2026. The split and appeal steps therefore overlap with the compliance deadline in the coming weeks.
The company is also seeking to complete a private financing it agreed to on November 15, with total consideration that could reach about $45.6 million. It said the first closing, expected in December 2026, could include subscriptions of about $15.6 million. The closing is subject, among other conditions, to shareholder approval for the issuance of securities. It also requires confirmation from Nasdaq that the company has remedied its listing deficiencies and that continued listing has been approved. This makes completion of the financing contingent on developments in the compliance and listing process, as well as obtaining the required approvals.
As for Innoviz, the available disclosure does not establish that it selected a 1-for-20 ratio or carried out a reverse split in its November 18 announcement. The company’s shareholders had authorized the board at a September 16 meeting to select a ratio within a range from 1-for-5 to 1-for-20. The company said Nasdaq granted it an additional compliance period, ending on March 22, 2027, to address the minimum bid price shortfall. It also notified Nasdaq of the possibility of using a reverse split if necessary. The authorized range and possible option therefore remain prior context; no information here confirms that a final ratio was selected.
In results published on November 11, Innoviz reported revenue of $12.1 million in the third quarter of 2026, compared with $15.3 million in the same period of 2025. The company also announced a reorganization planned for the fourth quarter of 2026 that includes a workforce reduction of about 20%. It said it expects the reorganization to generate annual savings of about $17.5 million compared with its current spending rate. The company updated its 2026 targets to include revenue of between $44 million and $46 million and wins of two to three new programs. These targets and operational measures form part of the company’s backdrop, alongside the additional compliance period that ends in March 2027.